Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
55.16 -0.14  -0.25% NYSE Apr 23, 4:59PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Investing (TTM):

863.67M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Investing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Investing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 863.67M
Sept. 30, 2013 -2.466B
June 30, 2013 -5.469B
March 31, 2013 -4.923B
Dec. 31, 2012 -4.240B
Sept. 30, 2012 -4.586B
June 30, 2012 -1.060B
March 31, 2012 -1.280B
Dec. 31, 2011 -172.66M
Sept. 30, 2011 -270.97M
June 30, 2011 -708.40M
March 31, 2011 -1.071B
Dec. 31, 2010 -2.896B
Sept. 30, 2010 -3.254B
June 30, 2010 -6.212B
March 31, 2010 -5.991B
Dec. 31, 2009 -6.451B
Sept. 30, 2009 -6.266B
June 30, 2009 -2.875B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

GSK Cash from Investing (TTM) Benchmarks

Companies
AstraZeneca -2.889B
Johnson & Johnson -5.103B
Eli Lilly and -2.073B

GSK Cash from Investing (TTM) Range, Past 5 Years

Minimum -6.451B Dec 2009
Maximum 863.67M Dec 2013
Average -3.122B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.